LILAK
Liberty Latin America Ltd.
$7.66
+0.66%
$1.7B
No data for this timeframe.
Vol
Market Cap$1.7B
Cap SizeSmall Cap
Exchange Nasdaq·Sector Cable & Other Pay Television Services·Inc. D0·CIK 0001712184·Prev Close $7.61
Price Targets
Historical data — last covering-analyst action Aug 2025. No current recommendation available.
$8.45 (Aug 2025)
Current $7.74
Low $7.40
Median $8.45
High $9.50
2 analysts
$7.40
$9.50
Analyst Ratings
2Strong Buy
4Buy
3Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Aug 28, 2025 | Scotiabank | MAINTAIN | Sector Perform → Sector Perform |
| Dec 4, 2024 | Goldman Sachs | MAINTAIN | Neutral → Neutral |
| Nov 8, 2024 | Scotiabank | MAINTAIN | Sector Outperform → Sector Outperform |
| Sep 4, 2024 | Goldman Sachs | DOWNGRADE | Buy → Neutral |
| Aug 12, 2024 | Pivotal Research | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.08 ▼ -9.6% | $0.08 — $0.08 | 104% YoY | 1 |
| Next Q | $0.12 ▼ -7.8% | $0.12 — $0.12 | 492% YoY | 1 |
| Current FY | $-0.15 ▼ -142.1% | $-0.68 — $0.38 | 95% YoY | 2 |
| Next FY | $0.87 ▼ -1.4% | $0.87 — $0.87 | 689% YoY | 1 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Aug 2025): 67% buy across 9 analysts — 2 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Aug 2025. No current recommendation available.
$8.45 mean target (Aug 2025)
$7.40 Low
$9.50 High
| Metric | Value |
|---|---|
| Current Price | $7.74 |
| Target Low | $7.40 |
| Target Mean | $8.45 |
| Target Median | $8.45 |
| Target High | $9.50 |
| # Analysts | 2 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.08 | $0.08 | $0.08 | 103.6% | -9.6% | 0↑ 1↓ | $1.1B | 0.7% | 1 |
| Next Q 2026-09-30 |
$0.12 | $0.12 | $0.12 | 491.6% | -7.8% | 0↑ 1↓ | $1.1B | 1.4% | 1 |
| Current FY 2026-12-31 |
$-0.15 | $-0.68 | $0.38 | 95.2% | -142.1% | 0↑ 2↓ | $4.4B | -1.9% | 2 |
| Next FY 2027-12-31 |
$0.87 | $0.87 | $0.87 | 689.1% | -1.4% | 0↑ 1↓ | $4.6B | 5.2% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.076 | |
| 7d ago | $0.084 | -0.008 |
| 30d ago | $0.084 | -0.008 |
| 60d ago | $0.084 | -0.008 |
| 90d ago | $0.145 | -0.069 |
5 analyst firms have rated this stock: 3 upgrades, 2 downgrades, 2 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Aug 28, 2025 | Scotiabank | MAINTAIN | Sector Perform | Sector Perform |
| Dec 4, 2024 | Goldman Sachs | MAINTAIN | Neutral | Neutral |
| Nov 8, 2024 | Scotiabank | MAINTAIN | Sector Outperform | Sector Outperform |
| Sep 4, 2024 | Goldman Sachs | DOWNGRADE | Buy | Neutral |
| Aug 12, 2024 | Pivotal Research | MAINTAIN | Buy | Buy |
| May 13, 2024 | Scotiabank | UPGRADE | Sector Perform | Sector Outperform |
| May 10, 2024 | Pivotal Research | MAINTAIN | Buy | Buy |
| May 18, 2023 | Scotiabank | DOWNGRADE | Outperform | Sector Perform |
| Apr 11, 2023 | Pivotal Research | MAINTAIN | — | Buy |
| Jul 18, 2022 | Pivotal Research | MAINTAIN | — | Buy |
| Mar 11, 2022 | Citigroup | MAINTAIN | — | Buy |
| Sep 28, 2020 | Scotiabank | UPGRADE | Sector Underperform | Sector Perform |
| May 20, 2020 | Citigroup | MAINTAIN | — | Buy |
| Oct 4, 2019 | Citigroup | MAINTAIN | — | Buy |
| Aug 27, 2018 | Citigroup | MAINTAIN | Buy | Buy |
| Apr 3, 2018 | Goldman Sachs | INITIATE | — | Neutral |
| Nov 13, 2017 | HSBC | UPGRADE | Reduce | Hold |
| Aug 15, 2016 | Citigroup | MAINTAIN | — | Buy |
| May 12, 2016 | Citigroup | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| May 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Apr 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Mar 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Feb 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% | |
| Jan 1, 2026 | 2 | 4 | 3 | 0 | 0 | 67% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.